Cargando…
ECMO in paediatric septic shock: an urgent need for prospective trial
Autores principales: | Beretta-Piccoli, Xavier, Biarent, Dominique, De Bels, David, Honore, Patrick M., Redant, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069187/ https://www.ncbi.nlm.nih.gov/pubmed/32164738 http://dx.doi.org/10.1186/s13054-020-2789-7 |
Ejemplares similares
-
Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: the jury is still out
por: Beretta-Piccoli, Xavier, et al.
Publicado: (2020) -
Anti-Xa activity and hemorrhagic event: isn’t it time to consider time ?
por: Redant, Sébastien, et al.
Publicado: (2021) -
Impact of CRRT in Patients with PARDS Treated with VV-ECMO
por: Redant, Sébastien, et al.
Publicado: (2021) -
Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
por: Honore, Patrick M., et al.
Publicado: (2018) -
Urgent need for a randomized controlled trial with only septic patients!
por: Redant, Sébastien, et al.
Publicado: (2019)